表紙
市場調查報告書

血栓消除設備的全球市場 - 至2022年的預測:吸引,機械性/擊潰,流體力學性,超音波血栓消除系統

Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022

出版商 MarketsandMarkets 商品編碼 495985
出版日期 內容資訊 英文 176 Pages
訂單完成後即時交付
價格
血栓消除設備的全球市場 - 至2022年的預測:吸引,機械性/擊潰,流體力學性,超音波血栓消除系統 Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022
出版日期: 2017年04月26日內容資訊: 英文 176 Pages
簡介

全球血栓消除設備市場,預計至2022年到14億5000萬美元擴大。預計市場2017年∼2022年以6.7%的年複合成長率成長。

本報告提供全球血栓消除設備市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 血栓消除系統:市場概述
  • 各地區分析:血栓消除系統市場,各應用
  • 各地區分析:血栓消除系統市場規模,各類型
  • 各地區分析:血栓消除系統市場規模,各終端用戶
  • 各地區分析:血栓消除系統市場,各國

第5章 血栓消除系統的全球市場:概要

  • 簡介
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
    • 市場課題
  • 研究開發平台分析

第6章 血栓消除系統的全球市場:產業考察

  • 簡介
  • 供應鏈分析
  • 產業趨勢
  • 波特的五力分析
  • 美國、德國的現在的償付方案

第7章 血栓消除系統的全球市場:各類型

  • 簡介
  • 吸引
  • 機械性/擊潰
  • 流體力學性
  • 超音波

第8章 血栓消除系統的全球市場:各應用

  • 簡介
  • 心臟血管
  • 神經血管
  • 末稍血管

第9章 血栓消除系統的全球市場:各終端用戶

  • 簡介
  • 醫院、外科中心
  • 門診外科中心
  • 研究所、學術機構
  • 其他

第10章 血栓消除系統的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第11章 競爭情形

  • 簡介
  • 供應商概要

第12章 企業簡介

  • 簡介
  • 主要企業
    • STRYKER CORPORATION
    • MEDTRONIC PLC
    • JOHNSON & JOHNSON
    • TERUMO CORPORATION
    • BOSTON SCIENTIFIC CORPORATION
    • SPECTRANETICS CORPORATION
    • PENUMBRA, INC.
    • ARGON MEDICAL DEVICES, INC.
    • EDWARDS LIFESCIENCES CORPORATION
    • TELEFLEX INCORPORATED
  • 新興企業
    • STRAUB MEDICAL AG
    • BTG INTERNATIONAL LTD.
    • PHENOX GMBH
    • ACANDIS GMBH & CO. KG

第13章 附錄

目錄
Product Code: MD 5202

The global thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period. The growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of this market. The factors such as increasing number of research activities in the field of thrombectomy and expanding application of ultrasound in vascular treatment are expected to offer renewed growth opportunities for market players during the forecast period.

In this report, the market has been segmented on the basis of type, application, end user, and region. Based on application, the cardiovascular segment commanded the largest share of the global thrombectomy devices market in 2016. This large market share is mainly attributed to factors such as increasing prevalence of cardiovascular diseases across major markets, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries.

Geographically, North America is estimated to command the largest share of the global thrombectomy devices market in 2016, followed by Europe. This large market share of the North American region can be attributed to increasing adoption of technologically advanced thrombectomy products, growing number of clinical trials, and significant medical reimbursement available in the U.S. for thrombectomy procedures.

Report Coverage:

This report studies global thrombectomy devices market based on type, application, and end user. The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the thrombectomy devices market report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the thrombectomy devices market.

Reasons to Buy the Report:

From an insights perspective, this research report is focused on various levels of analysis-industry trends and company profiles-which together discuss basic views on the competitive landscape, emerging and high growth segments of the thrombectomy devices market, and high growth regions and their respective drivers, restraints, opportunities, and challenges.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and in turn help firms garner greater shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the thrombectomy devices market. The report analyzes the market based on type, application, end user, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the thrombectomy devices market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various thrombectomy devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the thrombectomy devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the thrombectomy devices market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. OPPORTUNITY INDICATORS
      • 2.2.1.1. Rising geriatric population
      • 2.2.1.2. Number of hospitals and surgical centers
      • 2.2.1.3. Increased prevalence of cardiovascular diseases
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. THROMBECTOMY SYSTEM: MARKET SNAPSHOT (2017-2022)
  • 4.2. REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET, BY APPLICATION (2016)
  • 4.3. REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE (2017. VS. 2022)
  • 4.4. REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER (2017. VS. 2022)
  • 4.5. GEOGRAPHIC ANALYSIS: THROMBECTOMY SYSTEM MARKET, BY COUNTRY (2017-2022)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. Growing target patient population
      • 5.2.1.2. Ongoing technological advancements
      • 5.2.1.3. Favorable medical reimbursement scenario
      • 5.2.1.4. Increasing healthcare expenditure across emerging markets
      • 5.2.1.5. Rising demand for minimally invasive thrombectomy procedures
    • 5.2.2. KEY MARKET RESTRAINTS
      • 5.2.2.1. Stringent regulatory scenario
      • 5.2.2.2. Limited patient awareness related to thrombectomy resulting in delayed treatment for peripheral vascular diseases
    • 5.2.3. KEY MARKET OPPORTUNITIES
      • 5.2.3.1. Increasing number of research activities in the field of thrombectomy
      • 5.2.3.2. Expanding application of ultrasound in vascular treatment
    • 5.2.4. KEY MARKET CHALLENGES
      • 5.2.4.1. Limited availability of clinical data to validate the therapeutic efficacy of clot retrieval devices
      • 5.2.4.2. Dearth of skilled and well-trained surgeons
  • 5.3. RESEARCH PIPELINE ANALYSIS
    • 5.3.1. ASPIRATION THROMBECTOMY
    • 5.3.2. MECHANICAL THROMBECTOMY
    • 5.3.3. RHEOLYTIC THROMBECTOMY
    • 5.3.4. ULTRASONIC THROMBECTOMY

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. SUPPLY CHAIN ANALYSIS
    • 6.2.1. MAJOR STAKEHOLDERS
    • 6.2.2. KEY INFLUENCERS
  • 6.3. INDUSTRY TRENDS
    • 6.3.1. GROWING ADOPTION OF LASER-ASSISTED THROMBECTOMY
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
  • 6.5. CURRENT REIMBURSEMENT SCENARIO IN US AND GERMANY (AS OF DECEMBER 2016)

7. GLOBAL THROMBECTOMY SYSTEM MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. ASPIRATION THROMBECTOMY SYSTEM
  • 7.3. MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM
    • 7.3.1. STENT RETRIEVERS
    • 7.3.2. COIL RETRIEVERS
    • 7.3.3. BASKET/BRUSH RETRIEVERS
  • 7.4. RHEOLYTIC/HYDRODYNAMIC THROMBECTOMY SYSTEM
  • 7.5. ULTRASONIC THROMBECTOMY SYSTEM

8. GLOBAL THROMBECTOMY SYSTEM MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CARDIOVASCULAR APPLICATIONS
  • 8.3. NEUROVASCULAR APPLICATIONS
  • 8.4. PERIPHERAL VASCULAR APPLICATIONS

9. GLOBAL THROMBECTOMY SYSTEM MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS AND SURGICAL CENTERS
  • 9.3. AMBULATORY SURGICAL CENTERS
  • 9.4. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
  • 9.5. OTHER END USERS

10. THROMBECTOMY SYSTEM MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC
  • 10.5. REST OF THE WORLD
    • 10.5.1. LATIN AMERICA
    • 10.5.2. MIDDLE EAST AND AFRICA (MEA)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. VENDOR DIVE OVERVIEW
    • 11.2.1. VANGUARDS
    • 11.2.2. INNOVATORS
    • 11.2.3. DYNAMIC
    • 11.2.4. EMERGING

Top 25 companies analyzed for this studies are - Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Teleflex Incorporated (U.S.), Argon Medical Devices, Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Straub Medical Ag (Switzerland), BTG International (U.K.), Phenox GmbH (Germany), Acandis GmbH Co. & Kg (Germany), Merit Medical Systems, Inc. (U.S.), Minnetronix, Inc. (U.S.) NexGen Medical Systems, Inc. (U.S.), Capture Vascular (U.S.), Applied Medical (U.S.), Claret Medical (U.S.), Lemaitre Vascular (U.S.), Stentys (France), Dispomedical GmbH( Germany), Control Medical Tecyhnology (U.S.), and Natec Medical Ltd (Mauritius)

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
    • 12.1.1. GEOGRAPHIC BENCHMARKING
  • 12.2. TOP MARKET PLAYERS
    • 12.2.1. STRYKER CORPORATION
    • 12.2.2. MEDTRONIC PLC
    • 12.2.3. JOHNSON & JOHNSON
    • 12.2.4. TERUMO CORPORATION
    • 12.2.5. BOSTON SCIENTIFIC CORPORATION
    • 12.2.6. SPECTRANETICS CORPORATION
    • 12.2.7. PENUMBRA, INC.
    • 12.2.8. ARGON MEDICAL DEVICES, INC.
    • 12.2.9. EDWARDS LIFESCIENCES CORPORATION
    • 12.2.10. TELEFLEX INCORPORATED
  • 12.3. EMERGING PLAYERS
    • 12.3.1. STRAUB MEDICAL AG
    • 12.3.2. BTG INTERNATIONAL LTD.
    • 12.3.3. PHENOX GMBH
    • 12.3.4. ACANDIS GMBH & CO. KG

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. PRIMARY INSIGHTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: ASPIRATION THROMBECTOMY CATHETERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 2: CLOT RETRIEVERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 3: STENT RETRIEVERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 4: RHEOLYTIC THROMBECTOMY DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 5: ULTRASONIC THROMBECTOMY DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 6: MEDICAL REIMBURSEMENTS FOR THROMBECTOMY PROCEDURES (AS OF DECEMBER 2016)
  • TABLE 7: GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 8: ASPIRATION THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 10: MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: STENT RETRIEVERS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: COIL RETRIEVERS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: BASKET/BRUSH RETRIEVERS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: RHEOLYTIC/HYDRODYNAMIC THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: ULTRASONIC THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 17: THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: THROMBECTOMY SYSTEM MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: THROMBECTOMY SYSTEM MARKET SIZE FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: THROMBECTOMY SYSTEM MARKET SIZE FOR PERIPHERAL VASCULAR, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 22: THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: THROMBECTOMY SYSTEM MARKET SIZE FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: THROMBECTOMY SYSTEM MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: THROMBECTOMY SYSTEM MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: THROMBECTOMY SYSTEM MARKET SIZE FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: U.S.: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 33: U.S.: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 34: CANADA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 35: CANADA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 40: GERMANY: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 41: GERMANY: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 42: FRANCE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: FRANCE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: U.K.: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: U.K.: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 46: ROE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: ROE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: JAPAN: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 53: JAPAN: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 54: CHINA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: CHINA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: INDIA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: INDIA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 58: ROAPAC: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: ROAPAC: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 61: ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 63: ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: LATIN AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: LATIN AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 66: MIDDLE EAST & AFRICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: MIDDLE EAST & AFRICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES
  • FIGURE 3: INCREASE IN GERIATRIC POPULATION: BY COUNTRY (2010 VS. 2015)
  • FIGURE 4: INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION: BY COUNTRY (2011 VS. 2015 VS. 2030)
  • FIGURE 5: PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION (1980-2010 VS. 2010-2040)
  • FIGURE 6: BOTTOM-UP APPROACH
  • FIGURE 7: TOP-DOWN APPROACH
  • FIGURE 8: DATA TRIANGULATION
  • FIGURE 9: GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2017 VS. 2022
  • FIGURE 10: GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2017 VS. 2022
  • FIGURE 11: GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2017 VS. 2022
  • FIGURE 12: GEOGRAPHIC SNAPSHOT OF THE GLOBAL THROMBECTOMY SYSTEM MARKET
  • FIGURE 13: GROWING TARGET PATIENT POPULATION TO PROPEL THE DEMAND FOR THROMBECTOMY SYSTEM DURING THE FORECAST PERIOD
  • FIGURE 14: NORTH AMERICA DOMINATED THE THROMBECTOMY SYSTEM MARKET FOR ALL APPLICATION SEGMENTS IN 2016
  • FIGURE 15: MECHANICAL THROMBECTOMY SYSTEM SEGMENT WILL CONTINUE TO DOMINATE THE THROMBECTOMY SYSTEM MARKET ACROSS ALL REGIONS IN 2022
  • FIGURE 16: HOSPITALS & SURGICAL CENTERS WILL DOMINATE THE THROMBECTOMY SYSTEM MARKET ACROSS ALL REGIONS IN 2017
  • FIGURE 17: CHINA & INDIA ESTIMATED TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL THROMBECTOMY SYSTEM MARKET
  • FIGURE 18: THROMBECTOMY SYSTEM MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: PROPORTION OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, (2012 VS. 2020)
  • FIGURE 20: GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010-2015)
  • FIGURE 21: ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS OF DECEMBER 2016)
  • FIGURE 22: SUPPLY CHAIN ANALYSIS: THROMBECTOMY SYSTEM INDUSTRY
  • FIGURE 23: PORTER'S FIVE FORCES ANALYSIS (2016)
  • FIGURE 24: MECHANICAL THROMBECTOMY SYSTEM SEGMENT TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 25: STENT RETRIEVERS SEGMENT TO DOMINATE THE MECHANICAL THROMBECTOMY MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: NORTH AMERICA TO HOLD LARGEST SHARE OF THE ULTRASONIC THROMBECTOMY SYSTEM MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: CARDIOVASCULAR APPLICATIONS TO DOMINATE THE THROMBECTOMY SYSTEM MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: NORTH AMERICA TO HOLD LARGEST SHARE OF THE PERIPHERAL VASCULAR APPLICATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 29: HOSPITALS & SURGICAL CENTERS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 30: NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SNAPSHOT
  • FIGURE 31: EUROPE: THROMBECTOMY SYSTEM MARKET SNAPSHOT
  • FIGURE 32: ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SNAPSHOT
  • FIGURE 33: ROW: THROMBECTOMY SYSTEM MARKET SNAPSHOT
  • FIGURE 34: MNM DIVE - VENDOR COMPARISON MATRIX : THROMBECTOMY SYSTEM MARKET
  • FIGURE 35: ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE THROMBECTOMY SYSTEM MARKET (25 PLAYERS)
  • FIGURE 36: BUSINESS STRATEGY ADOPTED BY MAJOR PLAYERS IN THE THROMBECTOMY SYSTEM MARKET (25 PLAYERS)
  • FIGURE 37: GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS (AS OF 2016)
  • FIGURE 38: STRYKER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 39: STRYKER CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 40: STRYKER CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 41: MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 42: MEDTRONIC PLC: PRODUCT OFFERING SCORECARD
  • FIGURE 43: MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD
  • FIGURE 44: JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015)
  • FIGURE 45: JOHNSON & JOHNSON: PRODUCT OFFERING SCORECARD
  • FIGURE 46: JOHNSON & JOHNSON: BUSINESS STRATEGY SCORECARD
  • FIGURE 47: TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 48: TERUMO CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 49: TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 50: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 51: BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 52: BOSTON SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 53: SPECTRANETICS CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 54: SPECTRANETICS CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 55: SPECTRANETICS CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 56: PENUMBRA, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 57: PENUMBRA, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 58: PENUMBRA, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 59: ARGON MEDICAL DEVICES, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 60: ARGON MEDICAL DEVICES, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 61: EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 62: EDWARDS LIFESCIENCES CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 63: EDWARDS LIFESCIENCES CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 64: TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2016)
  • FIGURE 65: TELEFLEX INCORPORATED: PRODUCT OFFERING SCORECARD
  • FIGURE 66: TELEFLEX INCORPORATED: BUSINESS STRATEGY SCORECARD
  • FIGURE 67: STRAUB MEDICAL AG: PRODUCT OFFERING SCORECARD
  • FIGURE 68: STRAUB MEDICAL AG: BUSINESS STRATEGY SCORECARD
  • FIGURE 69: BTG INTERNATIONAL LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 70: BTG INTERNATIONAL LTD.: PRODUCT OFFERING SCORECARD
  • FIGURE 71: BTG INTERNATIONAL LTD.: BUSINESS STRATEGY SCORECARD
  • FIGURE 72: PHENOX GMBH: PRODUCT OFFERING SCORECARD
  • FIGURE 73: PHENOX GMBH: BUSINESS STRATEGY SCORECARD
  • FIGURE 74: ACANDIS GMBH: PRODUCT OFFERING SCORECARD
  • FIGURE 75: ACANDIS GMBH: BUSINESS STRATEGY SCORECARD